PPCB vs V · P/E 0.0, $3.9M cap vs P/E 33, rev $40.00B
Propanc Biopharma, Inc. Common Stock (PPCB) versus Visa Inc. Class A (V) — a side-by-side from cached financials, not a winner call.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Visa Inc. Class A (V) is a credit services company listed on US. It is led by Ryan McInerney.
PPCB does not have a complete income-statement cache yet.
Latest reported V revenue for 2025-09-30 was $40.00B. Net income was $20.06B. V currently screens at market cap $659.78B and trailing P/E 33.5.
PPCB currently screens at market cap $3.9M and trailing P/E 0.0. V currently screens at market cap $659.78B and trailing P/E 33.5.
Not investment advice. Open the PPCB and V stock pages for the full models.
Not investment advice.